Clinical cancer research : an official journal of the American Association for Cancer Research

Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan.

Clinical cancer research : an official journal of the American Association for Cancer Research

Gomez-Manzano C, Alonso MM, Yung WK, McCormick F, Curiel DT, Lang FF, Jiang H, Bekele BN, Zhou X, Alemany R, Fueyo J

Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG

Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.

Clinical cancer research : an official journal of the American Association for Cancer Research

Marchion DC, Bicaku E, Turner JG, Daud AI, Sullivan DM, Munster PN

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.

Clinical cancer research : an official journal of the American Association for Cancer Research

Marchion DC, Bicaku E, Turner JG, Daud AI, Sullivan DM, Munster PN

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

Clinical cancer research : an official journal of the American Association for Cancer Research

Cohen EE, Lingen MW, Martin LE, Harris PL, Brannigan BW, Haserlat SM, Okimoto RA, Sgroi DC, Dahiya S, Muir B, Clark JR, Rocco JW, Vokes EE, Haber DA, Bell DW

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

Clinical cancer research : an official journal of the American Association for Cancer Research

Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

Clinical cancer research : an official journal of the American Association for Cancer Research

Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG

Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Daud A, Valkov N, Centeno B, Derderian J, Sullivan P, Munster P, Urbas P, Deconti RC, Berghorn E, Liu Z, Hausheer F, Sullivan D

Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Daud A, Valkov N, Centeno B, Derderian J, Sullivan P, Munster P, Urbas P, Deconti RC, Berghorn E, Liu Z, Hausheer F, Sullivan D

Pages